GlassScriptPhysician profile
Sricharan Chalikonda
NPI 1568479145
$3,734.53
in general payments reported to CMS, 2019-2025
13 companies · $1,052 in 2025
The $1,052 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $610 · 2021: $189 · 2022: $360 · 2023: $256 · 2024: $1,268 · 2025: $1,052.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,261 · Travel and Lodging: $982 · Consulting Fee: $333.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,261.16 |
| Travel and Lodging | $981.98 |
| Consulting Fee | $332.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $791.05 | 2024 | |
| Distalmotion US | $639.67 | 2025 | Dexter L6 Robot |
| Ethicon US, LLC | $495.14 | 2021-2024 | Monocryl, Surgicel Nu-Knit, Surgiflo Hemostatic Matrix |
| Steris Instrument Management Services, INC. | $320.98 | 2019 | |
| Steris Corporation | $272.00 | 2019 | |
| Medical Device Business Services, INC. | $246.76 | 2021-2024 | Monocryl |
| Olympus America INC. | $228.04 | 2024-2025 | Hanarostent Esophagus Tts(Ccc), Endoclot Phs |
| Smith+Nephew, INC. | $206.77 | 2024-2025 | Renasys Go V2 Home, Pico, Renasys Touch |
| Boston Scientific Corporation | $158.37 | 2022 | |
| Integra Lifesciences Corporation | $130.38 | 2023 | Integra, Surgimend, Integra Dermal Regeneration Template |
| Acera Surgical, INC. | $117.69 | 2025 | Restrata Wound Matrix |
| W. L. Gore & Associates, INC. | $110.77 | 2025 | Gore Synecor Biomaterial |
| Stryker Corporation | $16.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sricharan Chalikonda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.